Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained CE Mark (Conformité Européenne) for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer for transfusion ...

RARITAN, N.J., May 3, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO ...

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...

RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...

RARITAN, NJ--(Marketwired - Oct 14, 2015) - Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received ...

Please provide your email address to receive an email when new articles are posted on . Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer ...

RARITAN, NJ--(Marketwired - Nov 12, 2015) - Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer, a ...

The revolutionary ORTHO VISION® analyzer is a highly interactive, fully automated blood bank analyzer engineered for the specific needs of transfusion medicine. Utilizing innovative ID-MTS ® gel ...

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that ORTHO Sera, a suite of extended antigen phenotyping, has been cleared by the US Food and Drug Administration for use ...

RARITAN, N.J., Oct. 18, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...